Rank | Gene Set | Z-score |
---|---|---|
1 | response to lipoprotein particle (GO:0055094) | 9.81293298 |
2 | response to lead ion (GO:0010288) | 9.52000433 |
3 | aminoglycoside antibiotic metabolic process (GO:0030647) | 9.46426004 |
4 | cellular response to vitamin D (GO:0071305) | 9.19746559 |
5 | sodium ion export (GO:0071436) | 8.30907146 |
6 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 8.28416593 |
7 | response to vitamin D (GO:0033280) | 8.25830829 |
8 | cellular potassium ion homeostasis (GO:0030007) | 7.75861229 |
9 | cellular response to vitamin (GO:0071295) | 7.34703240 |
10 | membrane repolarization during action potential (GO:0086011) | 7.28996888 |
11 | negative regulation of meiosis (GO:0045835) | 6.86605949 |
12 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 6.69188978 |
13 | response to hepatocyte growth factor (GO:0035728) | 6.69188978 |
14 | positive regulation of calcium ion import (GO:0090280) | 6.66818153 |
15 | drinking behavior (GO:0042756) | 6.50655770 |
16 | detection of molecule of bacterial origin (GO:0032490) | 6.40732306 |
17 | positive regulation of glycogen biosynthetic process (GO:0045725) | 6.32220098 |
18 | relaxation of cardiac muscle (GO:0055119) | 6.09219954 |
19 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 6.02426462 |
20 | negative regulation of macroautophagy (GO:0016242) | 5.97423094 |
21 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 5.76292474 |
22 | detection of calcium ion (GO:0005513) | 5.68812520 |
23 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 5.45508643 |
24 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 5.45052953 |
25 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 5.44702124 |
26 | positive regulation of glycogen metabolic process (GO:0070875) | 5.42883163 |
27 | auditory receptor cell stereocilium organization (GO:0060088) | 5.32708083 |
28 | regulation of activation of Janus kinase activity (GO:0010533) | 5.27893920 |
29 | cell communication by electrical coupling (GO:0010644) | 5.23385223 |
30 | neural tube formation (GO:0001841) | 5.18595436 |
31 | sulfate transmembrane transport (GO:1902358) | 5.15045363 |
32 | regulation of meiosis (GO:0040020) | 5.11432027 |
33 | negative regulation of digestive system process (GO:0060457) | 5.04286884 |
34 | positive regulation of glucose import (GO:0046326) | 5.03558364 |
35 | negative regulation of microtubule polymerization (GO:0031115) | 4.89721488 |
36 | negative regulation of appetite (GO:0032099) | 4.86288351 |
37 | negative regulation of response to food (GO:0032096) | 4.86288351 |
38 | membrane repolarization (GO:0086009) | 4.83850719 |
39 | cellular sodium ion homeostasis (GO:0006883) | 4.83807132 |
40 | chemosensory behavior (GO:0007635) | 4.75738339 |
41 | sulfate transport (GO:0008272) | 4.70466065 |
42 | bone resorption (GO:0045453) | 4.62667036 |
43 | energy homeostasis (GO:0097009) | 4.56757207 |
44 | response to pheromone (GO:0019236) | 4.56099952 |
45 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.53398755 |
46 | short-term memory (GO:0007614) | 4.43210969 |
47 | post-embryonic morphogenesis (GO:0009886) | 4.40244293 |
48 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 4.37485242 |
49 | hormone catabolic process (GO:0042447) | 4.34109599 |
50 | negative regulation of meiotic cell cycle (GO:0051447) | 4.31193572 |
51 | bone morphogenesis (GO:0060349) | 4.28940843 |
52 | positive regulation of glucose transport (GO:0010828) | 4.26775323 |
53 | potassium ion import (GO:0010107) | 4.25932254 |
54 | detection of external biotic stimulus (GO:0098581) | 4.22996419 |
55 | mannose metabolic process (GO:0006013) | 4.22471085 |
56 | negative regulation of cell size (GO:0045792) | 4.12560561 |
57 | potassium ion homeostasis (GO:0055075) | 4.09723862 |
58 | regulation of meiotic cell cycle (GO:0051445) | 4.06284918 |
59 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 4.05339680 |
60 | piRNA metabolic process (GO:0034587) | 3.98494304 |
61 | positive regulation of bone mineralization (GO:0030501) | 3.91830864 |
62 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.86543676 |
63 | positive regulation of neurological system process (GO:0031646) | 3.85350159 |
64 | inner ear receptor stereocilium organization (GO:0060122) | 3.83749359 |
65 | regulation of calcium ion import (GO:0090279) | 3.82493724 |
66 | estrogen biosynthetic process (GO:0006703) | 3.78956513 |
67 | regulation of mononuclear cell migration (GO:0071675) | 3.78185629 |
68 | positive regulation of biomineral tissue development (GO:0070169) | 3.78131553 |
69 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.74161359 |
70 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.70727154 |
71 | regulation of macrophage chemotaxis (GO:0010758) | 3.70314270 |
72 | regulation of appetite (GO:0032098) | 3.67513911 |
73 | cellular response to nutrient (GO:0031670) | 3.66241011 |
74 | female gonad development (GO:0008585) | 3.65639990 |
75 | thymus development (GO:0048538) | 3.60093573 |
76 | cell communication involved in cardiac conduction (GO:0086065) | 3.57574281 |
77 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.55083917 |
78 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.54910832 |
79 | DNA damage induced protein phosphorylation (GO:0006975) | 3.51282487 |
80 | prostate gland growth (GO:0060736) | 3.47040591 |
81 | DNA methylation involved in gamete generation (GO:0043046) | 3.46670215 |
82 | positive regulation of ATPase activity (GO:0032781) | 3.45709836 |
83 | positive regulation of ATP catabolic process (GO:1903291) | 3.45709836 |
84 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.45560600 |
85 | relaxation of muscle (GO:0090075) | 3.45557645 |
86 | detection of biotic stimulus (GO:0009595) | 3.44321702 |
87 | response to ischemia (GO:0002931) | 3.43992369 |
88 | regulation of feeding behavior (GO:0060259) | 3.43800615 |
89 | positive regulation of Rap GTPase activity (GO:0032854) | 3.43192096 |
90 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.39947080 |
91 | negative regulation of hormone metabolic process (GO:0032351) | 3.39947080 |
92 | negative regulation of mast cell activation (GO:0033004) | 3.38104812 |
93 | regulation of female gonad development (GO:2000194) | 3.36664986 |
94 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.35892792 |
95 | cAMP metabolic process (GO:0046058) | 3.33449383 |
96 | vitamin catabolic process (GO:0009111) | 3.33042003 |
97 | fat-soluble vitamin catabolic process (GO:0042363) | 3.33042003 |
98 | glutamate secretion (GO:0014047) | 3.28628071 |
99 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.28169633 |
100 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.26883750 |
101 | female gamete generation (GO:0007292) | 3.25449744 |
102 | male meiosis (GO:0007140) | 3.25106075 |
103 | peptide catabolic process (GO:0043171) | 3.21887460 |
104 | regulation of Rap GTPase activity (GO:0032317) | 3.15003263 |
105 | bicarbonate transport (GO:0015701) | 3.14462391 |
106 | meiotic chromosome segregation (GO:0045132) | 3.14048354 |
107 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.10931737 |
108 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.10454264 |
109 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.10454264 |
110 | regulation of response to food (GO:0032095) | 3.08596679 |
111 | cell wall macromolecule metabolic process (GO:0044036) | 3.06867615 |
112 | complement activation, alternative pathway (GO:0006957) | 3.06259346 |
113 | negative regulation of response to nutrient levels (GO:0032108) | 3.06256221 |
114 | negative regulation of response to extracellular stimulus (GO:0032105) | 3.06256221 |
115 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.05644346 |
116 | activation of MAPKKK activity (GO:0000185) | 3.05322624 |
117 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.01592327 |
118 | spermatid nucleus differentiation (GO:0007289) | 3.00956441 |
119 | meiotic cell cycle (GO:0051321) | 2.99581371 |
120 | serotonin receptor signaling pathway (GO:0007210) | 2.98233253 |
121 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.98154782 |
122 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.97518352 |
123 | inositol phosphate-mediated signaling (GO:0048016) | 2.97389502 |
124 | regulation of cardiac muscle contraction (GO:0055117) | 2.95561448 |
125 | myelin maintenance (GO:0043217) | 2.94523737 |
126 | positive regulation of potassium ion transport (GO:0043268) | 2.90514556 |
127 | mitotic metaphase plate congression (GO:0007080) | 2.90455830 |
128 | regulation of meiosis I (GO:0060631) | 2.90367451 |
129 | regulation of glucan biosynthetic process (GO:0010962) | 2.89209508 |
130 | regulation of glycogen biosynthetic process (GO:0005979) | 2.89209508 |
131 | N-glycan processing (GO:0006491) | 2.88551872 |
132 | regulation of glycogen metabolic process (GO:0070873) | 2.87338839 |
133 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.86627690 |
134 | embryonic epithelial tube formation (GO:0001838) | 2.86093141 |
135 | positive regulation of glucose metabolic process (GO:0010907) | 2.84805477 |
136 | lateral ventricle development (GO:0021670) | 2.83519663 |
137 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.82787361 |
138 | negative regulation of necrotic cell death (GO:0060547) | 2.82705493 |
139 | regulation of apoptotic cell clearance (GO:2000425) | 2.82138158 |
140 | regulation of glucocorticoid secretion (GO:2000849) | 2.81582870 |
141 | male meiosis I (GO:0007141) | 2.81480263 |
142 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.81254088 |
143 | polyol biosynthetic process (GO:0046173) | 2.80424683 |
144 | sulfur compound transport (GO:0072348) | 2.79809014 |
145 | proline transport (GO:0015824) | 2.78354961 |
146 | tachykinin receptor signaling pathway (GO:0007217) | 2.77918812 |
147 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.75990612 |
148 | type B pancreatic cell development (GO:0003323) | 2.75285080 |
149 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.75167382 |
150 | carnitine transmembrane transport (GO:1902603) | 2.74611203 |
151 | inositol metabolic process (GO:0006020) | 2.74497982 |
152 | regulation of exit from mitosis (GO:0007096) | 2.73721340 |
153 | centriole assembly (GO:0098534) | 2.72518860 |
154 | cellular response to gamma radiation (GO:0071480) | 2.71879921 |
155 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.70134451 |
156 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.68268197 |
157 | G-protein coupled receptor internalization (GO:0002031) | 2.65844953 |
158 | regulation of RIG-I signaling pathway (GO:0039535) | 2.63545940 |
159 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.62762101 |
160 | oocyte maturation (GO:0001556) | 2.61978039 |
161 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.61807630 |
162 | interferon-gamma production (GO:0032609) | 2.58354763 |
163 | glycerophospholipid catabolic process (GO:0046475) | 2.55463589 |
164 | negative regulation of nuclear division (GO:0051784) | 2.54736852 |
165 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.53855461 |
166 | histone H3-K36 demethylation (GO:0070544) | 2.52247269 |
167 | superoxide anion generation (GO:0042554) | 2.50421394 |
168 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 2.48431423 |
169 | sphingosine metabolic process (GO:0006670) | 2.47741309 |
170 | positive regulation of vascular permeability (GO:0043117) | 2.47478263 |
171 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.47433898 |
172 | maturation of 5.8S rRNA (GO:0000460) | 2.44073116 |
173 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.43971841 |
174 | replicative senescence (GO:0090399) | 2.43453238 |
175 | negative regulation of cell division (GO:0051782) | 2.41494149 |
176 | pyrimidine dimer repair (GO:0006290) | 2.39815892 |
177 | positive regulation of interleukin-17 production (GO:0032740) | 2.39026931 |
178 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.37514833 |
179 | aggressive behavior (GO:0002118) | 2.36592144 |
180 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.36411161 |
181 | protein K6-linked ubiquitination (GO:0085020) | 2.35189211 |
182 | protein-chromophore linkage (GO:0018298) | 2.34966414 |
183 | somatic stem cell division (GO:0048103) | 2.32080487 |
184 | positive regulation of protein sumoylation (GO:0033235) | 2.32073693 |
185 | glandular epithelial cell development (GO:0002068) | 2.30036191 |
186 | neuron remodeling (GO:0016322) | 2.28825423 |
187 | behavioral response to ethanol (GO:0048149) | 2.28464200 |
188 | positive regulation of meiosis (GO:0045836) | 2.27469394 |
189 | negative regulation of glial cell proliferation (GO:0060253) | 2.27161468 |
190 | histone H3-K9 modification (GO:0061647) | 2.25051516 |
191 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.24182590 |
192 | negative regulation of reproductive process (GO:2000242) | 2.24040153 |
193 | polyketide metabolic process (GO:0030638) | 14.8734024 |
194 | doxorubicin metabolic process (GO:0044598) | 14.8734024 |
195 | daunorubicin metabolic process (GO:0044597) | 14.8734024 |
196 | response to parathyroid hormone (GO:0071107) | 13.1205268 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 9.18159797 |
2 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.91339941 |
3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.50458243 |
4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.36826767 |
5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.35171406 |
6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.13049754 |
7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.12556434 |
8 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.64471916 |
9 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.47545447 |
10 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.41036751 |
11 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.29795784 |
12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.22196155 |
13 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 2.21293334 |
14 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.19604465 |
15 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.16696299 |
16 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.14223292 |
17 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 2.06506007 |
18 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.95854230 |
19 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.95481177 |
20 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.94847599 |
21 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.88334313 |
22 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.86168844 |
23 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.80427537 |
24 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.77898093 |
25 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.77122784 |
26 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.76462796 |
27 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.75316726 |
28 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.74639926 |
29 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.74546542 |
30 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.70986596 |
31 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.69622040 |
32 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.66817700 |
33 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.66817700 |
34 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.65337710 |
35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.65111766 |
36 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.65093681 |
37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.64650344 |
38 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.64462631 |
39 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.61142784 |
40 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.60533428 |
41 | FUS_26573619_Chip-Seq_HEK293_Human | 1.57287605 |
42 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.57274615 |
43 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.57250728 |
44 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.57055888 |
45 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.56486806 |
46 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.56178616 |
47 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.55904749 |
48 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.53378923 |
49 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.52649980 |
50 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.51927360 |
51 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.50507703 |
52 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.50231312 |
53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.48260047 |
54 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.47959256 |
55 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.47604336 |
56 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.47121522 |
57 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.46817192 |
58 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.46553307 |
59 | EWS_26573619_Chip-Seq_HEK293_Human | 1.45048807 |
60 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.44922960 |
61 | STAT3_23295773_ChIP-Seq_U87_Human | 1.44133411 |
62 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.43468211 |
63 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.43205948 |
64 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.42616842 |
65 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.41316283 |
66 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.41266879 |
67 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.40314256 |
68 | VDR_22108803_ChIP-Seq_LS180_Human | 1.39630152 |
69 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.35836283 |
70 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.35390556 |
71 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.34735162 |
72 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.34703709 |
73 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.33954529 |
74 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.33251467 |
75 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.32659176 |
76 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.32393604 |
77 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.31052644 |
78 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30370502 |
79 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.29601781 |
80 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29137540 |
81 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.28315663 |
82 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.28315663 |
83 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28308560 |
84 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.28132633 |
85 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.27815914 |
86 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.27605958 |
87 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27308614 |
88 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.26985488 |
89 | TCF4_23295773_ChIP-Seq_U87_Human | 1.26611672 |
90 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.26204915 |
91 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.25844364 |
92 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.25426095 |
93 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.24419532 |
94 | TBL1_22424771_ChIP-Seq_293T_Human | 1.23530022 |
95 | JUN_21703547_ChIP-Seq_K562_Human | 1.22276787 |
96 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.21420302 |
97 | RXR_22108803_ChIP-Seq_LS180_Human | 1.21130132 |
98 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.19897372 |
99 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.19132991 |
100 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.18747205 |
101 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.18641211 |
102 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.17508336 |
103 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.17443322 |
104 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.17295114 |
105 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.17096114 |
106 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.16630368 |
107 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.16133124 |
108 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.15515655 |
109 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.15092030 |
110 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.14551721 |
111 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.14548998 |
112 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.12716655 |
113 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12609863 |
114 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.12562314 |
115 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.12471439 |
116 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.11901068 |
117 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11676880 |
118 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.11130428 |
119 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11069678 |
120 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10930847 |
121 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.10862045 |
122 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.10451254 |
123 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10218318 |
124 | CBP_21632823_ChIP-Seq_H3396_Human | 1.10124884 |
125 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.10123888 |
126 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.09188829 |
127 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.08646390 |
128 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.08493922 |
129 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.08475236 |
130 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08149994 |
131 | NFYA_21822215_ChIP-Seq_K562_Human | 1.07522720 |
132 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.07318585 |
133 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06562425 |
134 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.05910859 |
135 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05520443 |
136 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.04841933 |
137 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.03991424 |
138 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.03636898 |
139 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.03501377 |
140 | GF1_26923725_Chip-Seq_HPCs_Mouse | 1.01342341 |
141 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01098504 |
142 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.00788203 |
143 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 1.00587135 |
144 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.98445529 |
145 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.97067538 |
146 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.96331416 |
147 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.96074262 |
148 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94191512 |
149 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.92655358 |
150 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.91088604 |
151 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90987563 |
152 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.87354298 |
153 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.87239021 |
154 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.86690061 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003195_calcinosis | 7.43524714 |
2 | MP0005367_renal/urinary_system_phenotyp | 5.38559960 |
3 | MP0000516_abnormal_urinary_system | 5.38559960 |
4 | MP0005377_hearing/vestibular/ear_phenot | 5.06354118 |
5 | MP0003878_abnormal_ear_physiology | 5.06354118 |
6 | MP0008004_abnormal_stomach_pH | 5.02945191 |
7 | MP0002909_abnormal_adrenal_gland | 4.84720656 |
8 | MP0006292_abnormal_olfactory_placode | 4.20439301 |
9 | MP0003646_muscle_fatigue | 3.84904982 |
10 | MP0002102_abnormal_ear_morphology | 3.84322126 |
11 | MP0000566_synostosis | 3.36744311 |
12 | MP0009697_abnormal_copulation | 3.19749932 |
13 | MP0003718_maternal_effect | 2.92622670 |
14 | MP0005451_abnormal_body_composition | 2.74868371 |
15 | MP0003879_abnormal_hair_cell | 2.65737178 |
16 | MP0005646_abnormal_pituitary_gland | 2.58532452 |
17 | MP0005645_abnormal_hypothalamus_physiol | 2.27157972 |
18 | MP0002638_abnormal_pupillary_reflex | 2.23568818 |
19 | * MP0000678_abnormal_parathyroid_gland | 11.9354683 |
20 | MP0002249_abnormal_larynx_morphology | 1.98869293 |
21 | MP0004742_abnormal_vestibular_system | 1.95017662 |
22 | MP0002735_abnormal_chemical_nociception | 1.93117642 |
23 | MP0001958_emphysema | 1.92925601 |
24 | MP0002163_abnormal_gland_morphology | 1.92021959 |
25 | MP0001485_abnormal_pinna_reflex | 1.90389648 |
26 | MP0003787_abnormal_imprinting | 1.88253540 |
27 | MP0008877_abnormal_DNA_methylation | 1.86200401 |
28 | MP0000733_abnormal_muscle_development | 1.81247965 |
29 | MP0001119_abnormal_female_reproductive | 1.79401690 |
30 | MP0002653_abnormal_ependyma_morphology | 1.76403902 |
31 | MP0010386_abnormal_urinary_bladder | 1.74389260 |
32 | MP0001986_abnormal_taste_sensitivity | 1.73039146 |
33 | MP0006276_abnormal_autonomic_nervous | 1.71910071 |
34 | MP0002736_abnormal_nociception_after | 1.69487645 |
35 | MP0004215_abnormal_myocardial_fiber | 1.67831707 |
36 | MP0004782_abnormal_surfactant_physiolog | 1.61143036 |
37 | MP0005310_abnormal_salivary_gland | 1.60515598 |
38 | MP0006072_abnormal_retinal_apoptosis | 1.60366491 |
39 | MP0003941_abnormal_skin_development | 1.56239046 |
40 | MP0002277_abnormal_respiratory_mucosa | 1.55760972 |
41 | MP0010094_abnormal_chromosome_stability | 1.52766159 |
42 | MP0002896_abnormal_bone_mineralization | 1.50231173 |
43 | MP0003329_amyloid_beta_deposits | 1.49183661 |
44 | MP0002168_other_aberrant_phenotype | 1.44047978 |
45 | MP0005171_absent_coat_pigmentation | 1.44004899 |
46 | MP0002938_white_spotting | 1.42043098 |
47 | MP0003693_abnormal_embryo_hatching | 1.41484719 |
48 | MP0004484_altered_response_of | 1.39712335 |
49 | MP0003656_abnormal_erythrocyte_physiolo | 1.38241440 |
50 | MP0001346_abnormal_lacrimal_gland | 1.37080603 |
51 | MP0001502_abnormal_circadian_rhythm | 1.33924153 |
52 | MP0003699_abnormal_female_reproductive | 1.33440015 |
53 | MP0000383_abnormal_hair_follicle | 1.31761535 |
54 | MP0001529_abnormal_vocalization | 1.29985084 |
55 | MP0005257_abnormal_intraocular_pressure | 1.28816976 |
56 | MP0005395_other_phenotype | 1.28594999 |
57 | MP0002932_abnormal_joint_morphology | 1.28041316 |
58 | MP0000163_abnormal_cartilage_morphology | 1.28017324 |
59 | MP0004019_abnormal_vitamin_homeostasis | 1.25251813 |
60 | MP0002132_abnormal_respiratory_system | 1.23516072 |
61 | MP0001968_abnormal_touch/_nociception | 1.22497634 |
62 | MP0003880_abnormal_central_pattern | 1.21836472 |
63 | MP0005423_abnormal_somatic_nervous | 1.21705133 |
64 | MP0001486_abnormal_startle_reflex | 1.19563654 |
65 | MP0003111_abnormal_nucleus_morphology | 1.16822904 |
66 | MP0003937_abnormal_limbs/digits/tail_de | 1.15817704 |
67 | MP0005551_abnormal_eye_electrophysiolog | 1.15771273 |
68 | MP0002108_abnormal_muscle_morphology | 1.14479459 |
69 | MP0000579_abnormal_nail_morphology | 1.13707983 |
70 | MP0004510_myositis | 1.13153014 |
71 | MP0008260_abnormal_autophagy | 1.10710182 |
72 | MP0003077_abnormal_cell_cycle | 1.08700320 |
73 | * MP0001765_abnormal_ion_homeostasis | 1.08527977 |
74 | MP0002210_abnormal_sex_determination | 1.06306174 |
75 | MP0009840_abnormal_foam_cell | 1.04966063 |
76 | MP0001984_abnormal_olfaction | 1.03496094 |
77 | MP0002396_abnormal_hematopoietic_system | 0.99600824 |
78 | MP0003300_gastrointestinal_ulcer | 0.97392327 |
79 | MP0000653_abnormal_sex_gland | 0.97334134 |
80 | MP0001790_abnormal_immune_system | 0.94227446 |
81 | MP0005387_immune_system_phenotype | 0.94227446 |
82 | MP0005647_abnormal_sex_gland | 0.92137013 |
83 | MP0001963_abnormal_hearing_physiology | 0.91649264 |
84 | MP0003136_yellow_coat_color | 0.91123873 |
85 | MP0008789_abnormal_olfactory_epithelium | 0.89819658 |
86 | MP0003283_abnormal_digestive_organ | 0.88555123 |
87 | MP0002098_abnormal_vibrissa_morphology | 0.88519674 |
88 | MP0005379_endocrine/exocrine_gland_phen | 0.88127760 |
89 | MP0010678_abnormal_skin_adnexa | 0.87902014 |
90 | MP0003121_genomic_imprinting | 0.87838724 |
91 | MP0000778_abnormal_nervous_system | 0.86006478 |
92 | MP0001929_abnormal_gametogenesis | 0.83201831 |
93 | MP0005390_skeleton_phenotype | 0.82845239 |
94 | MP0000026_abnormal_inner_ear | 0.82332981 |
95 | MP0000681_abnormal_thyroid_gland | 0.82018705 |
96 | MP0000569_abnormal_digit_pigmentation | 0.81698342 |
97 | MP0004859_abnormal_synaptic_plasticity | 0.80409123 |
98 | MP0003633_abnormal_nervous_system | 0.79377626 |
99 | MP0001905_abnormal_dopamine_level | 0.78941030 |
100 | MP0002557_abnormal_social/conspecific_i | 0.78630715 |
101 | MP0002572_abnormal_emotion/affect_behav | 0.78390074 |
102 | MP0005394_taste/olfaction_phenotype | 0.77910893 |
103 | MP0005499_abnormal_olfactory_system | 0.77910893 |
104 | MP0004924_abnormal_behavior | 0.77777881 |
105 | MP0005386_behavior/neurological_phenoty | 0.77777881 |
106 | MP0005408_hypopigmentation | 0.75153086 |
107 | MP0010030_abnormal_orbit_morphology | 0.73726297 |
108 | MP0002184_abnormal_innervation | 0.73594548 |
109 | MP0005248_abnormal_Harderian_gland | 0.72958810 |
110 | MP0003186_abnormal_redox_activity | 0.71812606 |
111 | MP0000013_abnormal_adipose_tissue | 0.71666177 |
112 | MP0005253_abnormal_eye_physiology | 0.70565924 |
113 | * MP0009643_abnormal_urine_homeostasis | 0.69541084 |
114 | MP0002233_abnormal_nose_morphology | 0.69041179 |
115 | MP0009250_abnormal_appendicular_skeleto | 0.68222405 |
116 | MP0005389_reproductive_system_phenotype | 0.68221793 |
117 | MP0003938_abnormal_ear_development | 0.67691319 |
118 | MP0002161_abnormal_fertility/fecundity | 0.65537645 |
119 | MP0002127_abnormal_cardiovascular_syste | 0.63851299 |
120 | MP0003763_abnormal_thymus_physiology | 0.62748400 |
121 | MP0008058_abnormal_DNA_repair | 0.62633948 |
122 | MP0003755_abnormal_palate_morphology | 0.62340260 |
123 | MP0001800_abnormal_humoral_immune | 0.61782981 |
124 | * MP0002113_abnormal_skeleton_development | 0.61666170 |
125 | MP0000613_abnormal_salivary_gland | 0.61197608 |
126 | MP0008007_abnormal_cellular_replicative | 0.61055239 |
127 | MP0003950_abnormal_plasma_membrane | 0.60834158 |
128 | MP0005671_abnormal_response_to | 0.60658660 |
129 | MP0000631_abnormal_neuroendocrine_gland | 0.60337771 |
130 | MP0000427_abnormal_hair_cycle | 0.59966524 |
131 | MP0001919_abnormal_reproductive_system | 0.59825035 |
132 | MP0003631_nervous_system_phenotype | 0.57592032 |
133 | MP0002177_abnormal_outer_ear | 0.57540889 |
134 | MP0000470_abnormal_stomach_morphology | 0.57217338 |
135 | MP0003936_abnormal_reproductive_system | 0.56650145 |
136 | MP0002234_abnormal_pharynx_morphology | 0.56626805 |
137 | MP0002063_abnormal_learning/memory/cond | 0.56390441 |
138 | MP0000604_amyloidosis | 0.55981574 |
139 | * MP0003795_abnormal_bone_structure | 0.55098783 |
140 | MP0000639_abnormal_adrenal_gland | 0.54999652 |
141 | MP0001188_hyperpigmentation | 0.54940974 |
142 | MP0001440_abnormal_grooming_behavior | 0.54852609 |
143 | MP0003698_abnormal_male_reproductive | 0.54331898 |
144 | MP0002751_abnormal_autonomic_nervous | 0.54193285 |
145 | MP0003638_abnormal_response/metabolism_ | 0.54181172 |
146 | MP0005508_abnormal_skeleton_morphology | 0.53320271 |
147 | MP0002148_abnormal_hypersensitivity_rea | 0.53287545 |
148 | MP0001145_abnormal_male_reproductive | 0.52929886 |
149 | MP0001970_abnormal_pain_threshold | 0.51952393 |
150 | MP0002734_abnormal_mechanical_nocicepti | 0.51923760 |
151 | MP0002067_abnormal_sensory_capabilities | 0.51452441 |
152 | MP0002116_abnormal_craniofacial_bone | 0.51211575 |
153 | MP0004858_abnormal_nervous_system | 0.50059834 |
154 | MP0000049_abnormal_middle_ear | 0.49199076 |
155 | MP0001664_abnormal_digestion | 0.49171826 |
156 | MP0002115_abnormal_skeleton_extremities | 0.48005156 |
157 | MP0000377_abnormal_hair_follicle | 0.47431763 |
158 | MP0003635_abnormal_synaptic_transmissio | 0.47291794 |
159 | MP0009379_abnormal_foot_pigmentation | 0.46225340 |
160 | MP0002064_seizures | 0.45745680 |
161 | MP0009745_abnormal_behavioral_response | 0.43552832 |
162 | MP0003137_abnormal_impulse_conducting | 0.43294690 |
163 | MP0000749_muscle_degeneration | 0.41935989 |
164 | MP0005501_abnormal_skin_physiology | 0.41477361 |
165 | * MP0003935_abnormal_craniofacial_develop | 0.41459936 |
166 | * MP0005636_abnormal_mineral_homeostasis | 0.40574986 |
167 | MP0001270_distended_abdomen | 0.39628177 |
168 | MP0002971_abnormal_brown_adipose | 0.38935679 |
169 | MP0010771_integument_phenotype | 0.37289307 |
170 | MP0000534_abnormal_ureter_morphology | 0.37087824 |
171 | MP0002229_neurodegeneration | 0.36841666 |
172 | MP0002796_impaired_skin_barrier | 0.36454913 |
173 | MP0005166_decreased_susceptibility_to | 0.35878579 |
174 | MP0004270_analgesia | 0.34782148 |
175 | MP0002160_abnormal_reproductive_system | 0.34585201 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Alacrima (HP:0000522) | 7.90353846 |
2 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 7.01173695 |
3 | Microretrognathia (HP:0000308) | 6.74866307 |
4 | Decreased lacrimation (HP:0000633) | 6.59799078 |
5 | Parakeratosis (HP:0001036) | 6.40747962 |
6 | Increased circulating renin level (HP:0000848) | 6.40658695 |
7 | Unilateral renal agenesis (HP:0000122) | 5.93474843 |
8 | Nasolacrimal duct obstruction (HP:0000579) | 5.79425966 |
9 | Mixed hearing impairment (HP:0000410) | 5.40132007 |
10 | J-shaped sella turcica (HP:0002680) | 5.32094870 |
11 | Conjugated hyperbilirubinemia (HP:0002908) | 5.16662038 |
12 | Bilateral sensorineural hearing impairment (HP:0008619) | 5.07903530 |
13 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 5.06455528 |
14 | Alopecia of scalp (HP:0002293) | 4.97988514 |
15 | Abnormal drinking behavior (HP:0030082) | 4.96476961 |
16 | Polydipsia (HP:0001959) | 4.96476961 |
17 | Abnormality of the lacrimal duct (HP:0011481) | 4.92203123 |
18 | Vacuolated lymphocytes (HP:0001922) | 4.89931052 |
19 | Metaphyseal irregularity (HP:0003025) | 4.89017020 |
20 | Preauricular pit (HP:0004467) | 4.87139407 |
21 | Periauricular skin pits (HP:0100277) | 4.87139407 |
22 | Absent eyebrow (HP:0002223) | 4.79980444 |
23 | Chromsome breakage (HP:0040012) | 4.66109118 |
24 | Follicular hyperkeratosis (HP:0007502) | 4.65609727 |
25 | * Hypoparathyroidism (HP:0000829) | 4.43715840 |
26 | Abnormality of dental color (HP:0011073) | 4.29792191 |
27 | Failure to thrive in infancy (HP:0001531) | 4.26994259 |
28 | Abnormality of the nasolacrimal system (HP:0000614) | 4.20927458 |
29 | Absent eyelashes (HP:0000561) | 4.12495791 |
30 | * Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.10885423 |
31 | * Hypocalcemia (HP:0002901) | 3.88338913 |
32 | Cheilitis (HP:0100825) | 3.76124940 |
33 | Hypomagnesemia (HP:0002917) | 3.64675093 |
34 | Scapular winging (HP:0003691) | 3.64659339 |
35 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.48149099 |
36 | Absent/shortened dynein arms (HP:0200106) | 3.48149099 |
37 | Retrobulbar optic neuritis (HP:0100654) | 3.47027509 |
38 | Optic neuritis (HP:0100653) | 3.47027509 |
39 | Polyuria (HP:0000103) | 3.46507400 |
40 | Recurrent corneal erosions (HP:0000495) | 3.44953662 |
41 | Ectropion (HP:0000656) | 3.36412932 |
42 | Generalized aminoaciduria (HP:0002909) | 3.30539968 |
43 | Ectopic kidney (HP:0000086) | 3.29534453 |
44 | Skin pits (HP:0100276) | 3.27113116 |
45 | Abnormality of renal excretion (HP:0011036) | 3.24281032 |
46 | Fair hair (HP:0002286) | 3.23416400 |
47 | Abnormality of renal resorption (HP:0011038) | 3.19233852 |
48 | Chronic otitis media (HP:0000389) | 3.18049841 |
49 | Abnormality of the antihelix (HP:0009738) | 3.17179172 |
50 | Abnormality of the costochondral junction (HP:0000919) | 3.16083316 |
51 | Intellectual disability, moderate (HP:0002342) | 3.15923916 |
52 | Hypokalemia (HP:0002900) | 3.13183563 |
53 | Deformed sella turcica (HP:0002681) | 3.12142951 |
54 | Hypergonadotropic hypogonadism (HP:0000815) | 3.05371935 |
55 | Renal Fanconi syndrome (HP:0001994) | 3.03395894 |
56 | Abnormality of magnesium homeostasis (HP:0004921) | 2.96407529 |
57 | Flat capital femoral epiphysis (HP:0003370) | 2.92043830 |
58 | Hyperparathyroidism (HP:0000843) | 2.91318363 |
59 | Abnormal urine output (HP:0012590) | 2.83432295 |
60 | Hypophosphatemic rickets (HP:0004912) | 2.77668957 |
61 | Abnormal ciliary motility (HP:0012262) | 2.75303620 |
62 | Generalized hypopigmentation of hair (HP:0011358) | 2.73810999 |
63 | Abolished electroretinogram (ERG) (HP:0000550) | 2.73670864 |
64 | Keratitis (HP:0000491) | 2.73497130 |
65 | Exotropia (HP:0000577) | 2.70458917 |
66 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.70426310 |
67 | Erythroderma (HP:0001019) | 2.69017703 |
68 | Abnormality of the renal collecting system (HP:0004742) | 2.69003214 |
69 | Duplicated collecting system (HP:0000081) | 2.67938909 |
70 | Renal dysplasia (HP:0000110) | 2.67401962 |
71 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.58569546 |
72 | Pancreatic fibrosis (HP:0100732) | 2.56277971 |
73 | Orchitis (HP:0100796) | 2.55542301 |
74 | Abnormality of the preputium (HP:0100587) | 2.54565299 |
75 | Abnormality of the dental root (HP:0006486) | 2.52838051 |
76 | Taurodontia (HP:0000679) | 2.52838051 |
77 | Abnormality of permanent molar morphology (HP:0011071) | 2.52838051 |
78 | Abnormality of renin-angiotensin system (HP:0000847) | 2.51629986 |
79 | Abnormality of incisor morphology (HP:0011063) | 2.51375935 |
80 | Septo-optic dysplasia (HP:0100842) | 2.50469073 |
81 | Symptomatic seizures (HP:0011145) | 2.48730590 |
82 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.47295905 |
83 | Hypoplasia of the fovea (HP:0007750) | 2.45654022 |
84 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.45654022 |
85 | Fetal akinesia sequence (HP:0001989) | 2.42195208 |
86 | Prostate neoplasm (HP:0100787) | 2.42066204 |
87 | Blepharitis (HP:0000498) | 2.40391888 |
88 | Type 2 muscle fiber atrophy (HP:0003554) | 2.40156625 |
89 | Small epiphyses (HP:0010585) | 2.38817562 |
90 | Chronic hepatic failure (HP:0100626) | 2.36650218 |
91 | Abnormality of molar (HP:0011077) | 2.35914497 |
92 | Abnormality of molar morphology (HP:0011070) | 2.35914497 |
93 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.34100295 |
94 | Hyperphosphaturia (HP:0003109) | 2.31585116 |
95 | Absent epiphyses (HP:0010577) | 2.30351167 |
96 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.30351167 |
97 | Adrenal hypoplasia (HP:0000835) | 2.29658141 |
98 | Inability to walk (HP:0002540) | 2.28767421 |
99 | Meckel diverticulum (HP:0002245) | 2.27918545 |
100 | Hypophosphatemia (HP:0002148) | 2.27436405 |
101 | Congenital sensorineural hearing impairment (HP:0008527) | 2.25486239 |
102 | Pancreatic cysts (HP:0001737) | 2.23608536 |
103 | Rhinitis (HP:0012384) | 2.22916331 |
104 | Abnormality of the dental pulp (HP:0006479) | 2.21582661 |
105 | True hermaphroditism (HP:0010459) | 2.21020655 |
106 | Myositis (HP:0100614) | 2.20663982 |
107 | Thickened calvaria (HP:0002684) | 2.20059955 |
108 | Absent hair (HP:0002298) | 2.19906611 |
109 | Sprengel anomaly (HP:0000912) | 2.19528510 |
110 | Abnormality of potassium homeostasis (HP:0011042) | 2.19274437 |
111 | Rickets (HP:0002748) | 2.18467077 |
112 | Clubbing of toes (HP:0100760) | 2.15005535 |
113 | Melanoma (HP:0002861) | 2.14393557 |
114 | Patellar aplasia (HP:0006443) | 2.13277997 |
115 | Abnormality of the ileum (HP:0001549) | 2.12507236 |
116 | Hypoglycemic seizures (HP:0002173) | 2.11303639 |
117 | Abnormal biliary tract physiology (HP:0012439) | 2.05461711 |
118 | Bile duct proliferation (HP:0001408) | 2.05461711 |
119 | Abnormality of chromosome stability (HP:0003220) | 2.05089141 |
120 | Neoplasm of the lung (HP:0100526) | 2.04558889 |
121 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.03739692 |
122 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.03739692 |
123 | Febrile seizures (HP:0002373) | 2.02539905 |
124 | Abnormality of the intervertebral disk (HP:0005108) | 2.00320507 |
125 | Absent septum pellucidum (HP:0001331) | 2.00315229 |
126 | * Tetany (HP:0001281) | 12.8096102 |
127 | * Hyperphosphatemia (HP:0002905) | 12.2288556 |
128 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 1.98742956 |
129 | Hypoplastic iliac wings (HP:0002866) | 1.97047217 |
130 | Abnormal hair whorl (HP:0010721) | 1.95838402 |
131 | Midline defect of the nose (HP:0004122) | 1.95024210 |
132 | Abnormality of the fovea (HP:0000493) | 1.94800128 |
133 | Abnormality of the labia minora (HP:0012880) | 1.94560732 |
134 | Male infertility (HP:0003251) | 1.94477885 |
135 | Shawl scrotum (HP:0000049) | 1.94003313 |
136 | Tachypnea (HP:0002789) | 1.93470765 |
137 | Abnormality of the sella turcica (HP:0002679) | 1.93305036 |
138 | Oligohydramnios (HP:0001562) | 1.92824465 |
139 | Capillary hemangiomas (HP:0005306) | 1.92557898 |
140 | Abnormality of DNA repair (HP:0003254) | 1.90404685 |
141 | Nephrocalcinosis (HP:0000121) | 1.90126558 |
142 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.89996393 |
143 | Abnormal urine phosphate concentration (HP:0012599) | 1.89215810 |
144 | Muscle fiber atrophy (HP:0100295) | 1.88288333 |
145 | Astigmatism (HP:0000483) | 1.88068871 |
146 | Arthropathy (HP:0003040) | 1.87976818 |
147 | Chronic sinusitis (HP:0011109) | 1.87627442 |
148 | Abnormality of the femoral head (HP:0003368) | 1.87406167 |
149 | Athetosis (HP:0002305) | 1.86732799 |
150 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.83663690 |
151 | Abnormality of femoral epiphyses (HP:0006499) | 1.83663690 |
152 | Atresia of the external auditory canal (HP:0000413) | 1.82181876 |
153 | Aplasia of the musculature (HP:0100854) | 1.82179889 |
154 | Renal agenesis (HP:0000104) | 1.81516438 |
155 | Increased serum pyruvate (HP:0003542) | 1.77940736 |
156 | Osteomalacia (HP:0002749) | 1.77711806 |
157 | Abnormality of alanine metabolism (HP:0010916) | 1.76881448 |
158 | Hyperalaninemia (HP:0003348) | 1.76881448 |
159 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.76881448 |
160 | Abnormality of the carotid arteries (HP:0005344) | 1.76549019 |
161 | Abnormality of the septum pellucidum (HP:0007375) | 1.76339994 |
162 | Birth length less than 3rd percentile (HP:0003561) | 1.75223996 |
163 | Hypercalciuria (HP:0002150) | 1.73532757 |
164 | Delayed puberty (HP:0000823) | 1.73516254 |
165 | Hyperactive renin-angiotensin system (HP:0000841) | 1.73235931 |
166 | Keratoconjunctivitis sicca (HP:0001097) | 1.72005992 |
167 | Tapered finger (HP:0001182) | 1.71477819 |
168 | Neoplasm of the respiratory system (HP:0100606) | 1.68778746 |
169 | Abnormality of the prostate (HP:0008775) | 1.67116150 |
170 | Absent radius (HP:0003974) | 1.65749335 |
171 | Absent forearm bone (HP:0003953) | 1.65083704 |
172 | Aplasia involving forearm bones (HP:0009822) | 1.65083704 |
173 | Aganglionic megacolon (HP:0002251) | 1.63174846 |
174 | Progressive neurologic deterioration (HP:0002344) | 1.60248470 |
175 | Abnormality of glycolysis (HP:0004366) | 1.60227562 |
176 | Vascular calcification (HP:0004934) | 1.58421679 |
177 | Hyponatremia (HP:0002902) | 1.56820100 |
178 | Death in childhood (HP:0003819) | 1.52181104 |
179 | Gait imbalance (HP:0002141) | 1.52021350 |
180 | Focal seizures (HP:0007359) | 1.49926365 |
181 | Congenital primary aphakia (HP:0007707) | 1.47491427 |
182 | Genital tract atresia (HP:0001827) | 1.43780256 |
183 | Tetraparesis (HP:0002273) | 1.43182506 |
184 | Rough bone trabeculation (HP:0100670) | 1.43074079 |
185 | Intrahepatic cholestasis (HP:0001406) | 1.40908718 |
186 | Vaginal atresia (HP:0000148) | 1.39455078 |
187 | Scanning speech (HP:0002168) | 1.39400704 |
188 | Basal ganglia calcification (HP:0002135) | 1.38095009 |
189 | Anosmia (HP:0000458) | 1.34286177 |
190 | Bundle branch block (HP:0011710) | 1.33486330 |
191 | Syncope (HP:0001279) | 1.32907453 |
192 | Oligodontia (HP:0000677) | 1.32758631 |
193 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.32436217 |
194 | Portal hypertension (HP:0001409) | 1.32126983 |
195 | Deep venous thrombosis (HP:0002625) | 1.31383881 |
196 | Infertility (HP:0000789) | 1.30548206 |
197 | Myokymia (HP:0002411) | 1.29844776 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K3 | 7.08380590 |
2 | PDK2 | 6.93647828 |
3 | SIK3 | 6.37643280 |
4 | MAP4K2 | 4.94693571 |
5 | SCYL2 | 4.50054116 |
6 | FLT3 | 4.03000024 |
7 | STK38L | 3.48559844 |
8 | SIK2 | 3.47407747 |
9 | LATS1 | 3.39296878 |
10 | MAP3K6 | 2.77555004 |
11 | MARK3 | 2.60812872 |
12 | LATS2 | 2.55191023 |
13 | SIK1 | 2.51798152 |
14 | PRKG2 | 2.39499239 |
15 | CASK | 2.37779589 |
16 | PLK4 | 2.33699339 |
17 | CDK8 | 2.30570645 |
18 | BRAF | 2.00948312 |
19 | MUSK | 1.96873479 |
20 | MAP2K7 | 1.95462289 |
21 | KIT | 1.94353846 |
22 | MAPK13 | 1.90646890 |
23 | TTK | 1.82956821 |
24 | CSF1R | 1.82413967 |
25 | BMPR2 | 1.80843927 |
26 | TAOK3 | 1.76153240 |
27 | MAP3K13 | 1.62925717 |
28 | ERBB4 | 1.60143594 |
29 | TXK | 1.59454985 |
30 | PRPF4B | 1.59266319 |
31 | SGK2 | 1.55006988 |
32 | BLK | 1.52857601 |
33 | PRKCG | 1.47664005 |
34 | NEK6 | 1.43728336 |
35 | TIE1 | 1.43144062 |
36 | RIPK1 | 1.33183934 |
37 | EPHA2 | 1.30634202 |
38 | EEF2K | 1.29336993 |
39 | STK3 | 1.29083252 |
40 | ZAK | 1.25494703 |
41 | CHEK2 | 1.24136814 |
42 | MARK1 | 1.23241545 |
43 | BMPR1B | 1.20372663 |
44 | MAP3K4 | 1.16881148 |
45 | MARK2 | 1.09273998 |
46 | KSR2 | 1.08173903 |
47 | RET | 1.06439807 |
48 | CDK3 | 1.05560357 |
49 | JAK3 | 1.04111245 |
50 | PRKD3 | 1.02391415 |
51 | STK38 | 1.01740749 |
52 | KSR1 | 1.00029342 |
53 | AKT3 | 0.96919744 |
54 | SGK223 | 0.93977075 |
55 | SGK494 | 0.93977075 |
56 | PAK6 | 0.93466203 |
57 | MOS | 0.91057049 |
58 | MKNK1 | 0.89756931 |
59 | CDK9 | 0.88602152 |
60 | MAP3K12 | 0.87879364 |
61 | MAP2K4 | 0.85892167 |
62 | DYRK2 | 0.85070338 |
63 | GSK3A | 0.82170966 |
64 | ADRBK2 | 0.81840846 |
65 | TRPM7 | 0.81616521 |
66 | NEK2 | 0.79659640 |
67 | VRK1 | 0.79589899 |
68 | MAP3K1 | 0.79038761 |
69 | MAPK15 | 0.77153665 |
70 | RAF1 | 0.75945927 |
71 | MKNK2 | 0.74442155 |
72 | EPHA4 | 0.72634542 |
73 | MAPK7 | 0.71576392 |
74 | SGK3 | 0.71521148 |
75 | PRKAA2 | 0.71465872 |
76 | BCKDK | 0.71444592 |
77 | NTRK2 | 0.71190426 |
78 | CDC7 | 0.69433878 |
79 | PRKAA1 | 0.68844269 |
80 | MAP3K5 | 0.66902434 |
81 | MET | 0.66856795 |
82 | MST4 | 0.65692177 |
83 | MELK | 0.65262367 |
84 | CSNK1A1 | 0.65065964 |
85 | EPHB2 | 0.65009490 |
86 | STK10 | 0.64138687 |
87 | MAP3K9 | 0.63300865 |
88 | TAOK2 | 0.62980247 |
89 | FGR | 0.62053901 |
90 | TNIK | 0.61779253 |
91 | MAPK4 | 0.61774362 |
92 | PAK4 | 0.61732578 |
93 | ADRBK1 | 0.61557890 |
94 | PLK2 | 0.61494516 |
95 | MINK1 | 0.60298237 |
96 | PRKD2 | 0.57780695 |
97 | EIF2AK2 | 0.57666572 |
98 | PINK1 | 0.57446312 |
99 | TEC | 0.56527068 |
100 | CAMK2D | 0.56167333 |
101 | MAPK12 | 0.55779886 |
102 | WNK3 | 0.55553901 |
103 | PKN1 | 0.55365286 |
104 | EIF2AK1 | 0.55121467 |
105 | PRKD1 | 0.55046234 |
106 | ZAP70 | 0.54368715 |
107 | PLK3 | 0.51987487 |
108 | NLK | 0.51846425 |
109 | YES1 | 0.51547055 |
110 | NUAK1 | 0.50728297 |
111 | TESK2 | 0.49905754 |
112 | MAPK11 | 0.49123836 |
113 | CAMK4 | 0.48465905 |
114 | PAK3 | 0.47266541 |
115 | PHKG2 | 0.47076161 |
116 | PHKG1 | 0.47076161 |
117 | INSRR | 0.46942343 |
118 | MAPKAPK5 | 0.46367889 |
119 | MAPKAPK3 | 0.45284078 |
120 | PLK1 | 0.42355309 |
121 | MYLK | 0.42016539 |
122 | CSNK1D | 0.41844459 |
123 | STK24 | 0.41825387 |
124 | CDK7 | 0.41638579 |
125 | TAOK1 | 0.40926674 |
126 | PAK2 | 0.39371068 |
127 | PRKACA | 0.37939262 |
128 | ERBB2 | 0.37599793 |
129 | PDK1 | 0.37532591 |
130 | MAP3K7 | 0.37322821 |
131 | MAP3K14 | 0.37012681 |
132 | CAMK2A | 0.35686762 |
133 | GRK1 | 0.35577281 |
134 | STK16 | 0.34920290 |
135 | PRKCE | 0.34476031 |
136 | PRKCQ | 0.34036822 |
137 | CSNK1E | 0.33980252 |
138 | BCR | 0.33497987 |
139 | CSNK1G1 | 0.33422645 |
140 | PDPK1 | 0.33091554 |
141 | ACVR1B | 0.32982360 |
142 | CAMK1D | 0.32595704 |
143 | PRKCB | 0.32075793 |
144 | MAPK3 | 0.31091975 |
145 | MAP2K1 | 0.30657618 |
146 | CAMKK2 | 0.30389362 |
147 | NTRK3 | 0.30327410 |
148 | OBSCN | 0.30154089 |
149 | ICK | 0.29850482 |
150 | PIM2 | 0.29489994 |
151 | CHEK1 | 0.29440183 |
152 | DYRK1A | 0.29135449 |
153 | WNK4 | 0.29121320 |
154 | CSNK1G2 | 0.27764320 |
155 | CAMK1 | 0.27646529 |
156 | PRKCA | 0.27217384 |
157 | ATR | 0.25668008 |
158 | RPS6KA4 | 0.25372400 |
159 | PDGFRA | 0.24881031 |
160 | ROCK1 | 0.24591007 |
161 | ABL2 | 0.24290607 |
162 | EPHA3 | 0.23596623 |
163 | TYK2 | 0.23193357 |
164 | IKBKE | 0.22475250 |
165 | AKT2 | 0.21926886 |
166 | CAMK2G | 0.20552083 |
167 | MAPK1 | 0.20381128 |
168 | PAK1 | 0.20360383 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 5.18521380 |
2 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 3.22846298 |
3 | Phototransduction_Homo sapiens_hsa04744 | 3.22702356 |
4 | Gastric acid secretion_Homo sapiens_hsa04971 | 2.93400835 |
5 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.90988643 |
6 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 2.73833236 |
7 | Basal transcription factors_Homo sapiens_hsa03022 | 2.52711545 |
8 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.43868392 |
9 | Circadian rhythm_Homo sapiens_hsa04710 | 2.42422469 |
10 | Cell cycle_Homo sapiens_hsa04110 | 2.33422789 |
11 | Nicotine addiction_Homo sapiens_hsa05033 | 2.30048192 |
12 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.24984016 |
13 | Salivary secretion_Homo sapiens_hsa04970 | 2.20394567 |
14 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.14903319 |
15 | RNA degradation_Homo sapiens_hsa03018 | 1.92647487 |
16 | Bile secretion_Homo sapiens_hsa04976 | 1.80547003 |
17 | Homologous recombination_Homo sapiens_hsa03440 | 1.78124416 |
18 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.77943984 |
19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.70590611 |
20 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.66483732 |
21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.63057603 |
22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.59051762 |
23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.58422387 |
24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.57833929 |
25 | GABAergic synapse_Homo sapiens_hsa04727 | 1.56196431 |
26 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.55692281 |
27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.54627087 |
28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.53051911 |
29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.42519513 |
30 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.42420957 |
31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.40875336 |
32 | Mineral absorption_Homo sapiens_hsa04978 | 1.40874397 |
33 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.40855154 |
34 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.40795528 |
35 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.40689029 |
36 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.39547949 |
37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.38973271 |
38 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.35834195 |
39 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.33508177 |
40 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.33164557 |
41 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.30694156 |
42 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.28742136 |
43 | Insulin secretion_Homo sapiens_hsa04911 | 1.27595147 |
44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.24721792 |
45 | Measles_Homo sapiens_hsa05162 | 1.24335353 |
46 | Renin secretion_Homo sapiens_hsa04924 | 1.22154631 |
47 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21945157 |
48 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21652329 |
49 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.21419847 |
50 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.21269222 |
51 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.20634793 |
52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.20589489 |
53 | Morphine addiction_Homo sapiens_hsa05032 | 1.19730377 |
54 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.17340397 |
55 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.16807467 |
56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15891141 |
57 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.15075761 |
58 | Taste transduction_Homo sapiens_hsa04742 | 1.14687855 |
59 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.13749997 |
60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.12818382 |
61 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.10999575 |
62 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.10367813 |
63 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.09246583 |
64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.06462216 |
65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.03696757 |
66 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.03202717 |
67 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.02157164 |
68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.01508637 |
69 | Melanoma_Homo sapiens_hsa05218 | 0.99490112 |
70 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.98503384 |
71 | Allograft rejection_Homo sapiens_hsa05330 | 0.98239505 |
72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96809938 |
73 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96603340 |
74 | Lysosome_Homo sapiens_hsa04142 | 0.91964960 |
75 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.91754404 |
76 | Gap junction_Homo sapiens_hsa04540 | 0.91539483 |
77 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.90463495 |
78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89193441 |
79 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.88667311 |
80 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.88354981 |
81 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.87378340 |
82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87375032 |
83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.87258153 |
84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86819205 |
85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.86079384 |
86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85727610 |
87 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85657777 |
88 | Tuberculosis_Homo sapiens_hsa05152 | 0.84568795 |
89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83742404 |
90 | Cocaine addiction_Homo sapiens_hsa05030 | 0.83306272 |
91 | Base excision repair_Homo sapiens_hsa03410 | 0.82217983 |
92 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.80977885 |
93 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.80752579 |
94 | Influenza A_Homo sapiens_hsa05164 | 0.79900579 |
95 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.79770424 |
96 | RNA polymerase_Homo sapiens_hsa03020 | 0.79240506 |
97 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.77940024 |
98 | Axon guidance_Homo sapiens_hsa04360 | 0.76459125 |
99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76314645 |
100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74979632 |
101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.73603770 |
102 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.72983525 |
103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72862290 |
104 | Hepatitis B_Homo sapiens_hsa05161 | 0.72620878 |
105 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.72616663 |
106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72351464 |
107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70142291 |
108 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.69951382 |
109 | Long-term depression_Homo sapiens_hsa04730 | 0.68877087 |
110 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.68206631 |
111 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68018259 |
112 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67689174 |
113 | Malaria_Homo sapiens_hsa05144 | 0.65689662 |
114 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.64743383 |
115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62153047 |
116 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61541996 |
117 | Adherens junction_Homo sapiens_hsa04520 | 0.61533497 |
118 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60950858 |
119 | Leishmaniasis_Homo sapiens_hsa05140 | 0.60465749 |
120 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.58967856 |
121 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.58688624 |
122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58483344 |
123 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58462674 |
124 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.58416318 |
125 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57966130 |
126 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57338740 |
127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57166879 |
128 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56712172 |
129 | Purine metabolism_Homo sapiens_hsa00230 | 0.56518508 |
130 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.56249046 |
131 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.55408712 |
132 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.54308625 |
133 | Tight junction_Homo sapiens_hsa04530 | 0.53881133 |
134 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.50543091 |
135 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.50444789 |
136 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.50258771 |
137 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.49888104 |
138 | Olfactory transduction_Homo sapiens_hsa04740 | 0.49625624 |
139 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49444215 |
140 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49408628 |
141 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.48757192 |
142 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48715784 |
143 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48000646 |
144 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46842335 |
145 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46781694 |
146 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46510217 |
147 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.46363644 |
148 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.46069391 |
149 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.45517508 |
150 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44203058 |
151 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.43085233 |
152 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.42730058 |
153 | Circadian entrainment_Homo sapiens_hsa04713 | 0.42259115 |
154 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.37810901 |
155 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37247206 |
156 | Platelet activation_Homo sapiens_hsa04611 | 0.37240095 |
157 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.36409737 |
158 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36084879 |
159 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.34896818 |
160 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.32007610 |
161 | Peroxisome_Homo sapiens_hsa04146 | 0.28520295 |
162 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27976292 |
163 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.26743863 |
164 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24901905 |
165 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.22325301 |
166 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.22158549 |
167 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.20991996 |
168 | Protein export_Homo sapiens_hsa03060 | 0.16463468 |
169 | Long-term potentiation_Homo sapiens_hsa04720 | 0.14417921 |
170 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.13953219 |